Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Topics in Medicinal Chemistry
  4. Volume 24, Issue 23
  5. Article
Volume 24, Issue 23
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Recently, a large number of novel heterocyclic compounds and their derivatives have been synthesized, and studies on their biological functions have been conducted. Even though the triazole moiety of this scaffold appears to be fairly small, many researchers are interested in it because of its biological profile and variety of potential uses. Triazole derivatives have been synthesized and published by various researchers as their important characteristic against various diseases. Several researchers are interested in this scaffold because of its biological profile and wide variety of potential uses, even if its triazole moiety seems to be somewhat less. The derivative of this heterocyclic ring produced various biological activities such as anti-inflammatory, anticonvulsant, hypoglycemic, antitubercular, anxiolytic, antimicrobial, antitumor, and anticancer. The current review article focuses on pharmacological profile associated with triazoles and mainly focuses on structural modification done for various targets, along with a brief description of targets.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ctmc/10.2174/0115680266308359240708094001
2024-09-01
2025-07-05

  • From This Site

    /content/journals/ctmc/10.2174/0115680266308359240708094001
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Karaca GençerH. Acar ÇevikU. LeventS. SağlıkB. KorkutB. ÖzkayY. IlgınS. ÖztürkY. New benzimidazole-1,2,4-triazole hybrid compounds: Synthesis, anticandidal activity and cytotoxicity evaluation.Molecules201722450710.3390/molecules22040507 28346364
     [Google Scholar]
  2. MansooryJ.H. RajputS.S. Synthesis, reactivity and biological evaluation of triazole: recent developments.IJPPS2015752032
     [Google Scholar]
  3. UygunY. BayrakH. ÖzkanH. Synthesis and biological activities of methylenebis-4$H$-1,2,4-triazole derivatives.Turk. J. Chem.20133781282410.3906/kim‑1212‑66
     [Google Scholar]
  4. Lala RamJ. VandanaS. RichaA. A Review on Synthesis and Biological Activity of 1,2,4-triazole Derivatives.Int. J. Pharm. Sci. Rev. Res.20237918491
     [Google Scholar]
  5. Al-OmarM.A. Al-AbdullahE.S. ShehataI.A. HabibE.E. IbrahimT.M. El-EmamA.A. Synthesis, antimicrobial, and anti-inflammatory activities of novel 5-(1-adamantyl)-4-arylidene- amino-3-mercapto-1,2,4-triazoles and related derivatives.Molecules20101542526255010.3390/molecules15042526 20428062
     [Google Scholar]
  6. KharbR. SharmaP.C. YarM.S. Pharmacological significance of triazole scaffold.J. Enzyme Inhib. Med. Chem.201126112110.3109/14756360903524304 20583859
     [Google Scholar]
  7. SargsyanA.B. AvakyanA.S. VartanyanS.O. StepanyanG.M. ParonikyanR.V. Synthesis of new 1,4-benzodioxanyl-1,2,4-triazole derivatives.Russ. J. Gen. Chem.201888483984210.1134/S1070363218040345
     [Google Scholar]
  8. Bezerra MoraisP.A. JavariniC.L. ValimT.C. FranciscoC.S. de Freitas FerreiraL.C. Trancoso BottocimR.R. NetoÁ.C. JúniorV.L. RamonR. NetoÁ.C. JúniorV.L. Triazole: A New Perspective in Medicinal Chemistry and Material Science.Curr. Org. Chem.202226181691170210.2174/1385272827666221213145147
     [Google Scholar]
  9. ShafieiM. PeytonL. HashemzadehM. ForoumadiA. History of the development of antifungal azoles: A review on structures, SAR, and mechanism of action.Bioorg. Chem.202010410424010.1016/j.bioorg.2020.104240 32906036
     [Google Scholar]
  10. GomhaS. AhmedS. AbdelhamidA. Synthesis and cytotoxicity evaluation of some novel thiazoles, thiadiazoles, and pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5(1H)-ones incorporating triazole moiety.Molecules20152011357137610.3390/molecules20011357 25594346
     [Google Scholar]
  11. SharmaB. VermaA. PrajapatiS. SharmaU.K. Synthetic methods, chemistry, and the anticonvulsant activity of thiadiazoles.Int. J. Med. Chem.2013201311610.1155/2013/348948 25405032
     [Google Scholar]
  12. IdreesM. KolaS. SiddiquiN.J. Synthesis of Novel Series of Quinolino[3,2-f][1,2,4]triazolo[3,4-b][1,3,4]-thiadiazepines Derivatives Incorporated with 3-[5-(benzofuran-2-yl)-1-phenyl-1H-pyrazol-3-yl] Moiety as Potent Antimicrobial Agent.Asian J. Chem.20183092129213310.14233/ajchem.2018.21483
     [Google Scholar]
  13. ZahranF. Abdel LatifF. SayedA. ShabanR. KeshtaA. Biological studies of the effect of some new synthetic triazole derivatives on Ehrlich Ascites Carcinoma cells.Int J Biol Pharm Res20134261270
     [Google Scholar]
  14. KhanS.A. ImamS.M. AhmadA. BashaS.H. HusainA. Synthesis, molecular docking with COX 1& II enzyme, ADMET screening and in vivo anti-inflammatory activity of oxadiazole, thiadiazole and triazole analogs of felbinac.J. Saudi Chem. Soc.201822446948410.1016/j.jscs.2017.05.006
     [Google Scholar]
  15. PrajapatiS. GoswamiK. PatalA. Synthesis and characterisation of 4-Aryl thiazole ring system and its antimicrobial activity.Int. J. Pharma Bio Sci.201341803808
     [Google Scholar]
  16. FrolovaY. Design, synthesis, antimicrobial and antifungal activities of new 1,2,4-triazole derivatives containing 1H-tetrazole moiety.Ankara Universitesi Eczacilik Fakultesi Dergisi2020441708810.33483/jfpau.574001
     [Google Scholar]
  17. SinghR. ChouhanA. Important methods of synthesis and biological significance of 1,2,4-triazole derivatives.World J. Pharm. Pharm. Sci.201438874906
     [Google Scholar]
  18. KumarR. YarM.S. ChaturvediS. SrivastavaA. Triazole as pharmaceuticals potentials.Int. J. Pharm. Tech. Res.2013518441869
     [Google Scholar]
  19. Alagarsamy, V synthesis and antimicrobial activity of compound 1,4-disubstituted-1,2,4-triazolo[4,3-a]-quinazolin-5(4H)-ones.Asian J. Biiochem. Pharmaceut. Res.2011188101
     [Google Scholar]
  20. DatarP. synthesis and anticancer activity of compound imidazolidinyl-triazolidin-5-thione derivatives.Asian J. Biiochem. Pharmaceut. Res.2011188101
     [Google Scholar]
  21. DanilchenkoD.M. SafonovA.A. Diuretic activity of 2-((4-amino-5-R-4H-1,2,4-triazole-3-yl)thio)acetohydrazides.Zaporozhye Medical Journal20170451751910.14739/2310‑1210.2017.4.105283
     [Google Scholar]
  22. IhnatovaT. KaplaushenkoA. FrolovaY. PryhloE. Synthesis and antioxidant properties of some new 5-phenethyl-3-thio-1,2,4-triazoles.Pharmacia202168112913310.3897/pharmacia.68.e53320
     [Google Scholar]
  23. PageA.V. LilesW.C. Posaconazole: A new agent for the prevention and management of severe, refractory or invasive fungal infections.Can. J. Infect. Dis. Med. Microbiol.200819429730510.1155/2008/825901 19436511
     [Google Scholar]
  24. HollierL.M. CoxS.M. Fluconazole (Diflucan®).Infect. Dis. Obstet. Gynecol.19953622222510.1155/S1064744995000676 18476045
     [Google Scholar]
  25. ArikanS. RexJ.H. Ravuconazole Eisai/Bristol-Myers Squibb.Curr. Opin. Investig. Drugs200234555561 12090723
     [Google Scholar]
  26. PrenticeA.G. GlasmacherA. Making sense of itraconazole pharmacokinetics.J. Antimicrob. Chemother.200556Suppl. 1i17i2210.1093/jac/dki220 16120630
     [Google Scholar]
  27. ThomasE. GhanyM.G. LiangT.J. The application and mechanism of action of ribavirin in therapy of hepatitis C.Antivir. Chem. Chemother.2012231112
     [Google Scholar]
  28. JuergensS. Alprazolam and diazepam: Addiction potential.J. Subst. Abuse Treat.199181-2435110.1016/0740‑5472(91)90026‑7 2051498
     [Google Scholar]
  29. WattsC. MartinT.L. Etizolam Blood Concentrations in 191 Forensic Cases in Ontario, Canada (2019-2020).J. Anal. Toxicol.202246771972510.1093/jat/bkab106 34570874
     [Google Scholar]
  30. CalderonA. SoldanS.S. De LeoA. DengZ. FraseD.M. AndersonE.M. ZhangY. VladimirovaO. LuF. LeungJ.C. MurphyM.E. LiebermanP.M. Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism.Oncotarget202011464224424210.18632/oncotarget.27815 33245718
     [Google Scholar]
  31. NeuH.C. FuK.P. Cefatrizine activity compared with that of other cephalosporins.Antimicrob. Agents Chemother.197915220921210.1128/AAC.15.2.209 426514
     [Google Scholar]
  32. ShahP.J. RyznerK.L. Evaluating the appropriate use of piperacillin/tazobactam in a community health system: a retrospective chart review.P&T2013388462483 24222978
     [Google Scholar]
  33. WrightJ.M. MusiniV.M. GillR. First-line drugs for hypertension.Cochrane Database Syst. Rev.201844CD001841 29667175
     [Google Scholar]
  34. MiocM. AvramS. BerceanV. KuruncziL. GhiulaiR.M. OpreanC. CoricovacD.E. DeheleanC. MiocA. Balan-PorcarasuM. TatuC. SoicaC. Design, synthesis and biological activity evaluation of S-substituted 1H-5-mercapto-1,2,4-triazole derivatives as antiproliferative agents in colorectal cancer.Front Chem.2018637310.3389/fchem.2018.00373 30234098
     [Google Scholar]
  35. PagniezF. LebouvierN. NaY.M. Ourliac-GarnierI. PicotC. Le BorgneM. Le PapeP. Biological exploration of a novel 1,2,4-triazole-indole hybrid molecule as antifungal agent.J. Enzyme Inhib. Med. Chem.202035139840310.1080/14756366.2019.1705292 31899979
     [Google Scholar]
  36. PalekarV.S. DamleA.J. ShuklaS.R. Synthesis and antibacterial activity of some novel bis-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and bis-4-thiazolidinone derivatives from terephthalic dihydrazide.Eur. J. Med. Chem.200944125112511610.1016/j.ejmech.2009.07.023 19683841
     [Google Scholar]
  37. JacobJ.H. IrshaidF.I. Al-SoudY.A. Antibacterial activity of some selected 1,2,4-triazole derivatives against standard, environmental, and medical bacterial strains.Adv. Stud. Biol.20135629130110.12988/asb.2013.3418
     [Google Scholar]
  38. LipeevaA.V. ZakharovD.O. BurovaL.G. FrolovaT.S. BaevD.S. ShirokikhI.V. EvstropovA.N. SinitsynaO.I. TolsikovaT.G. ShultsE.E. Design, synthesis and antibacterial activity of coumarin-1,2,3-triazole hybrids obtained from natural furocoumarin peucedanin.Molecules201924112126214910.3390/molecules24112126 31195697
     [Google Scholar]
  39. Turan-ZitouniG. KaplancıklıZ.A. YıldızM.T. ChevalletP. KayaD. Synthesis and antimicrobial activity of 4-phenyl/cyclohe-xyl-5-(1-phenoxyethyl)-3-[N-(2-thiazolyl)acetamido]thio-4H-1,2,] 4-triazole derivatives.Eur. J. Med. Chem.200540660761310.1016/j.ejmech.2005.01.007 15922844
     [Google Scholar]
  40. HollaB.S. MahalingaM. KarthikeyanM.S. PoojaryB. AkberaliP.M. KumariN.S. Synthesis, characterization and antimicrobial activity of some substituted 1,2,3-triazoles.Eur. J. Med. Chem.200540111173117810.1016/j.ejmech.2005.02.013 15979767
     [Google Scholar]
  41. YangL. GeS. HuangJ. BaoX. Synthesis of novel (E)-2-(4-(1H-1,2,4-triazol-1-yl)styryl)-4- (alkyl/arylmethyleneoxy)quinazo-line derivatives as antimicrobial agents.Mol. Divers.2018221718210.1007/s11030‑017‑9792‑1 29119421
     [Google Scholar]
  42. BektaşH. KaraaliN. ŞahinD. DemirbaşA. KaraogluŞ.A. DemirbaşN. Synthesis and Antimicrobial Activities of Some New 1,2,4-Triazole Derivatives.Molecules20101542427243810.3390/molecules15042427 20428053
     [Google Scholar]
  43. IsloorA.M. KallurayaB. ShettyP. Regioselective reaction: Synthesis, characterization and pharmacological studies of some new Mannich bases derived from 1,2,4-triazoles.Eur. J. Med. Chem.20094493784378710.1016/j.ejmech.2009.04.038 19464087
     [Google Scholar]
  44. PokrovskayaV. BelakhovV. HainrichsonM. YaronS. BaasovT. Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics.J. Med. Chem.20095282243225410.1021/jm900028n 19301822
     [Google Scholar]
  45. SobhiM.G. MastouraM.E. ZeinabA.M. NabilaA.K. Sraa AbuM. AmirahM.S. Synthesis, Characterization, and Antimicrobial Evaluation of Some New 1,4-Dihydropyridines-1,2,4-Triazole Hybrid Compounds.Polycycl. Aromat. Compd.2020
     [Google Scholar]
  46. SniderD.E. RaviglioneM.Jr KochiA. Global burden of tuberculosis, chapter 1.Tuberculosis: Pathogenisis, Protection, and ControlAmerican society for MicrobiologyWashington, DC 20005.1994311
     [Google Scholar]
  47. BallellL. FieldR.A. DuncanK. YoungR.J. New small-molecule synthetic antimycobacterials.Antimicrob. Agents Chemother.20054962153216310.1128/AAC.49.6.2153‑2163.2005 15917508
     [Google Scholar]
  48. SpigelmanM.K. New tuberculosis therapeutics: a growing pipeline.J. Infect. Dis.2007196s1Suppl. 1S28S3410.1086/518663 17624823
     [Google Scholar]
  49. BoechatN. FerreiraV.F. FerreiraS.B. FerreiraM.L.G. da SilvaF.C. BastosM.M. CostaM.S. LourençoM.C.S. PintoA.C. KrettliA.U. AguiarA.C. TeixeiraB.M. da SilvaN.V. MartinsP.R.C. BezerraF.A.F.M. CamiloA.L.S. da SilvaG.P. CostaC.C.P. Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.J. Med. Chem.201154175988599910.1021/jm2003624 21776985
     [Google Scholar]
  50. RamprasadJ. Kumar SthalamV. Linga Murthy ThampunuriR. BhukyaS. UmmanniR. BalasubramanianS. PabbarajaS. Synthesis and evaluation of a novel quinoline-triazole analogs for antitubercular properties via molecular hybridization approach.Bioorg. Med. Chem. Lett.2019292012667110.1016/j.bmcl.2019.126671 31526604
     [Google Scholar]
  51. GillC. JadhavG. ShaikhM. KaleR. GhawalkarA. NagargojeD. ShiradkarM. Clubbed [1,2,3] triazoles by fluorine benzimidazole: A novel approach to H37Rv inhibitors as a potential treatment for tuberculosis.Bioorg. Med. Chem. Lett.200818236244624710.1016/j.bmcl.2008.09.096 18930654
     [Google Scholar]
  52. ÖzdemirA. Turan-ZitouniG. Asim KaplancikliZ. ChevalletP. Synthesis of some 4-arylidenamino-4H-1,2,4-triazole-3-thiols and their antituberculosis activity.J. Enzyme Inhib. Med. Chem.200722451151610.1080/14756360601178424 17847720
     [Google Scholar]
  53. KüçükgüzelI. KüçükgüzelS.G. RollasS. KirazM. Some 3-Thioxo/alkylthio-1,2,4-triazoles with a substituted thiourea moiety as possible antimycobacterials.Bioorg. Med. Chem. Lett.200111131703170710.1016/S0960‑894X(01)00283‑9 11425542
     [Google Scholar]
  54. SinghR. KashawS.K. MishraV.K. MishraM. RajoriyaV. KashawV. Design and Synthesis of New Bioactive 1,2,4-Triazoles, Potential Antitubercular and Antimicrobial Agents.Indian J. Pharm. Sci.2018801364510.4172/pharmaceutical‑sciences.1000328 23901159
     [Google Scholar]
  55. ShiradkarM. Suresh KumarG.V. DasariV. TatikondaS. AkulaK.C. ShahR. Clubbed triazoles: A novel approach to antitubercular drugs.Eur. J. Med. Chem.200742680781610.1016/j.ejmech.2006.12.001 17239490
     [Google Scholar]
  56. KaplancikliZ.A. Turan-ZitouniG. ChevalletP. Synthesis and antituberculosis activity of new 3-alkylsulfanyl-1,2,4-triazole derivatives.J. Enzyme Inhib. Med. Chem.200520217918210.1080/14756360500043471 15968822
     [Google Scholar]
  57. SravanthiB. KaviarasanL. PraveenT.K. PindiproluS.S. Sai Kiran.; Pavankumar, C; Gowramma, B. Synthesis and Pharmacological Evaluation of 1, 3, 4-Thiadiazole bearing Pyrimidine Derivatives as STAT3 Inhibitor for Treatment of Breast Cancer.J. Indian Chem. Soc.20201723592370
     [Google Scholar]
  58. KaviarasanL. GowrammaB. KalirajanR. MevithraM. ChandralekhaS. Molecular docking studies and synthesis of a new class of chroman 4 one fused 1,3,4 thiadiazole derivatives and evaluation for their anticancer potential.J. Indian Chem. Soc.20201720832094
     [Google Scholar]
  59. KaviarasanL. GowrammaB. ManalM. A Brief Review on Dual Target of PARP1 and STAT3 for Cancer Therapy: A Novel Perception.Curr. Enzym. Inhib.202016120
     [Google Scholar]
  60. LakshmananK. ByranG. BandlamudiS. KrishnamurthyP.T. The Role of STAT3 Signaling in Different Types of Cancers: A Comprehensive Review.Curr. Enzym. Inhib.202016318919810.2174/1573408016999200708160300
     [Google Scholar]
  61. DilipkumarS. KarthikV. DkS. GowrammaB. LakshmananK. In-silico screening and molecular dynamics simulation of quinazolinone derivatives as PARP1 and STAT3 dual inhibitors: a novel DML approaches.J. Biomol. Struct. Dyn.202311110.1080/07391102.2023.2259476 37735921
     [Google Scholar]
  62. FarghalyT.A.E.R. AbdallahM.A. MahmoudH.K. Synthesis of novel 1,2,4-triazoles and triazolo-thiadiazines as anticancer agents.Turk. J. Chem.20153995596910.3906/kim‑1504‑13
     [Google Scholar]
  63. YangJ.G. PanF.Y. New 3-[(4-Hydroxy-6-Methly-2(1H)-Pyridinones)-3-yl]-4-Substituted-(1H)-1,2,4-Triazole-5-Thiones: Efficient Synthesis, X-Ray Crystallographic Analysis, and Antitumor Activity.Lett. Org. Chem.20074213714110.2174/157017807780414181
     [Google Scholar]
  64. GomhaS.M. Abdel-azizH.M. BadreyM.G. AbdullaM.M. Efficient Synthesis of Some New 1,3,4‐Thiadiazoles and 1,2,4‐Triazoles Linked to Pyrazolylcoumarin Ring System as Potent 5α‐Reductase Inhibitors.J. Heterocycl. Chem.20195641275128210.1002/jhet.3487
     [Google Scholar]
  65. ZhaiX. ZhaoY.F. LiuY.J. ZhangY. XunF.Q. LiuJ. GongP. Synthesis and cytotoxicity studies of novel[1,2,4]tria-zolo[1,5-a]pyrimidine-7-amines.Chem. Pharm. Bull. (Tokyo)200856794194510.1248/cpb.56.941 18591806
     [Google Scholar]
  66. DhawanS. AwoladeP. KistenP. CeleN. PillayA.S. SahaS. KaurM. JonnalagaddaS.B. SinghP. Synthesis, cytotoxicity and antimicrobial evaluation of new coumarin-tagged beta-lactam triazole hybrid.Chem. Biodivers.2020171e190046210.1002/cbdv.201900462 31788939
     [Google Scholar]
  67. CarreteroO.A. OparilS. Essential Hypertension.Circulation2000101332933510.1161/01.CIR.101.3.329 10645931
     [Google Scholar]
  68. Guyton.; Hall.; John E. Hall Textbook of Medical Physiology.Elsevier2005Vol. 7
     [Google Scholar]
  69. ChobanianA.V. BakrisG.L. BlackH.R. CushmanW.C. GreenL.A. IzzoJ.L.Jr JonesD.W. MatersonB.J. OparilS. WrightJ.T.Jr RoccellaE.J. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure.Hypertension20034261206125210.1161/01.HYP.0000107251.49515.c2 14656957
     [Google Scholar]
  70. AshtonW.T. CantoneC.L. ChangL.L. HutchinsS.M. StrelitzR.A. MacCossM. ChangR.S.L. LottiV.J. FaustK.A. ChenT.B. Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazoles.J. Med. Chem.199336559160910.1021/jm00057a009 8496939
     [Google Scholar]
  71. OkazakiT. SugaA. WatanabeT. KikuchiK. KuriharaH. ShibasakiM. FujimoriA. InagakiO. YanagisawaU. Studies on nonpeptide angiotensin II receptor antagonists. I. Synthesis and biological evaluation of pyrazolo[1,5-b][1,2,4]triazole derivatives with alkyl substituents.Chem. Pharm. Bull. (Tokyo)1998461697810.1248/cpb.46.69 9468638
     [Google Scholar]
  72. KakefudaA. SuzukiT. TobeT. TsukadaJ. TaharaA. SakamotoS. TsukamotoS. Synthesis and pharmacological evaluation of 5-(4-biphenyl)-3-methyl-4-phenyl-1,2,4-triazole derivatives as a novel class of selective antagonists for the human vasopressin V(1A) receptor.J. Med. Chem.200245122589259810.1021/jm010544r 12036368
     [Google Scholar]
  73. PapatheodorouK. BanachM. BekiariE. RizzoM. EdmondsM. Complications of Diabetes 2017.J. Diabetes Res.201820181410.1155/2018/3086167 29713648
     [Google Scholar]
  74. LeRoithD. BiesselsG.J. BraithwaiteS.S. CasanuevaF.F. DrazninB. HalterJ.B. HirschI.B. McDonnellM.E. MolitchM.E. MuradM.H. SinclairA.J. Treatment of diabetes in older adults: an endocrine society clinical practice guideline.J. Clin. Endocrinol. Metab.201910451520157410.1210/jc.2019‑00198 30903688
     [Google Scholar]
  75. Gout-ZwartJ.J. de JongL.A. SaptennoL. PostmaM.J. Budget impact analysis of metformin sustained release for the treatment of type 2 diabetes in the Netherlands.PharmacoEconom. Open20204232133010.1007/s41669‑019‑00179‑6 31535305
     [Google Scholar]
  76. ZhuY. OlsonS.H. GrahamD. PatelG. Hermanowski-VosatkaA. MundtS. ShahK. SpringerM. ThieringerR. WrightS. XiaoJ. ZokianH. DragovicJ. BalkovecJ.M. Phenylcyclobutyl triazoles as selective inhibitors of 11β-hydroxy-] steroid dehydrogenase type I.Bioorg. Med. Chem. Lett.200818113412341610.1016/j.bmcl.2008.04.014 18440812
     [Google Scholar]
  77. EbdrupS. SørensenL.G. OlsenO.H. JacobsenP. Synthesis and structure-activity relationship for a novel class of potent and selective carbamoyl-triazole based inhibitors of hormone sensitive lipase.J. Med. Chem.200447240041010.1021/jm031004s 14711311
     [Google Scholar]
  78. MohamedM.A.A. Abd AllahO.A. BekhitA.A. KadryA.M. El-SaghierA.M.M. Synthesis and antidiabetic activity of novel triazole derivatives containing amino acids.J. Heterocycl. Chem.20205762365237810.1002/jhet.3951
     [Google Scholar]
  79. KarakurtA. AytemirM.D. StablesJ.P. ÖzalpM. Betül KaynakF. ÖzbeyS. DalkaraS. Synthesis of some oxime ether derivatives of 1-(2-naphthyl)-2-(1,2,4-triazol-1-yl)ethanone and their anticonvulsant and antimicrobial activities.Arch. Pharm. (Weinheim)2006339951352010.1002/ardp.200500248 16941729
     [Google Scholar]
  80. PraveenS. KumarA. ParveenB.R. Sonu.; Pal, H. Synthesis and biological evaluation of some new Schiff base 1,2,4-triazole derivatives.IJPC2017769599
     [Google Scholar]
  81. PoulsenS.A. WilkinsonB.L. InnocentiA. VulloD. SupuranC.T. Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzenesulfonamide derivatives.Bioorg. Med. Chem. Lett.200818164624462710.1016/j.bmcl.2008.07.010 18644716
     [Google Scholar]
  82. DobbsK.D. FeldmanJ. MarshallW.J. McLainS.J. McLarenC.D. MethJ.S. VoG.D. WangY. Phosphorescent Iridium(III) Complexes of Cyclometalated 5-Aryl-1 H -1,2,4-Triazole Ligands: Structural, Computational, Spectroscopic, and Device Studies.J. Phys. Chem. C201411848277632777110.1021/jp5096322
     [Google Scholar]
  83. IzattR.M. LindhG.C. BrueningR.L. HuszthyP. McDanielC.W. BradshawJ.S. ChristensenJ.J. Separation of silver from other metal cations using pyridone and triazole macrocycles in liquid membrane systems.Anal. Chem.198860171694169910.1021/ac00168a013
     [Google Scholar]
  84. UllmannA.J. CornelyO.A. BurchardtA. Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection.Antimicrob. Agents Chemother.200650265866610.1128/AAC.50.2.658‑666.2006
     [Google Scholar]
  85. RüpingM.J.G.T. AlbermannN. EbingerF. BurckhardtI. BeiselC. MüllerC. VehreschildJ.J. KochanekM. FätkenheuerG. BangardC. UllmannA.J. HerrW. KolbeK. HallekM. CornelyO.A. Posaconazole concentrations in the central nervous system.J. Antimicrob. Chemother.20086261468147010.1093/jac/dkn409 18824458
     [Google Scholar]
/content/journals/ctmc/10.2174/0115680266308359240708094001
Loading
A Pharmacological Update of Triazole Derivative: A Review
Curr. Top. Med. Chem. 24, 2033 (2024); https://doi.org/10.2174/0115680266308359240708094001
/content/journals/ctmc/10.2174/0115680266308359240708094001
/content/journals/ctmc/10.2174/0115680266308359240708094001
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Heterocyclic compound; Hypoglycemic; Pharmacological activity; SAR; Scaffold; Triazole

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test